Comparing ERK signaling and tumor microenvironment in BRAF-altered gliomas.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.2063
Abstract: 2063 Background: Many patients with BRAF-altered glioma (V600E mutations, fusions) respond to BRAF inhibitors (BRAFi), but some—particularly those with high-grade gliomas (HGG)—progress on treatment. Here, we aim to assess MAPK/ERK activation associated with various BRAF… read more here.
Keywords: mapk erk; v600e fusions; braf; v600e ... See more keywords